Subscribe To

Price Alert Latest News Economic Calendar News

CDXS / Codexis stock drops as forecast comes in below Street estimate

Codexis Inc. CDXS shares fell in the extended session Thursday after the biotech company lowered its revenue forecast for the year and said that sales from Pfizer Inc. PFE would come in at the low end of an expected range. Codexis shares dropped more than 20% after hours, following a 4.7% decline in the regular session to close at $12.07. Read More

Demo Live Account See Partner Details

Content Topics

Codexis

Stock

Drops

Forecast

Comes

Below

Street

Estimate

CDXS

Posted: Jul 14 2022, 17:19

Author Name: Market Watch

CDXS News

By Seeking Alpha
November 2, 2023

Codexis, Inc. (CDXS) Q3 2023 Earnings Call Transcript

By GlobeNewsWire
October 27, 2023

Codexis to Present Update on ECO Synthesis™ Platform at TIDES Europe

REDWOOD CITY, Calif., Oct. 27, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced a presenta

By Seeking Alpha
October 5, 2023

Checking Out Codexis

Codexis, Inc. is undergoing a significant restructuring to reduce costs, refocus its developmental efforts and streamline its organization. The compan

By Zacks Investment Research
September 11, 2023

Codexis (CDXS) Transfers Leasing Rights to Vaxcyte, Stock Up

Codexis (CDXS) transfers the leasing rights of its San Carlos, CA location to Vaxcyte to focus on technology development, inducing cost savings, to ex

By Seeking Alpha
February 23, 2023

Codexis, Inc. (CDXS) Q4 2022 Earnings Call Transcript

Codexis, Inc. (NASDAQ:CDXS ) Q4 2022 Earnings Conference Call February 23, 2023 4:30 PM ET Company Participants Stephen Dilly - President, CEO & Direc

By Zacks Investment Research
February 23, 2023

Codexis (CDXS) Reports Q4 Loss, Tops Revenue Estimates

Codexis (CDXS) delivered earnings and revenue surprises of 17.39% and 4.30%, respectively, for the quarter ended December 2022. Do the numbers hold cl

By Seeking Alpha
November 5, 2022

Codexis, Inc. (CDXS) Q3 2022 Earnings Call Transcript

Codexis, Inc. (NASDAQ:CDXS ) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Brendan Strong - Argot Partners Dr. Ste

By Zacks Investment Research
November 3, 2022

Codexis (CDXS) Reports Q3 Loss, Tops Revenue Estimates

Codexis (CDXS) delivered earnings and revenue surprises of 16.67% and 9.74%, respectively, for the quarter ended September 2022. Do the numbers hold c

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.